James Patrick Tursi

Chief Medical Officer, AUXILIUM PHARMACEUTICALS INC.

Companies

MetaVia Inc.Board member Nov 2, 2023 to now¹
Endo International plcExecutive VP, Global R&D Feb 24, 2022 to Aug 17, 2022²
AGILE THERAPEUTICS INCBoard member Oct 2, 2014 to Jun 10, 2022³
ANTARES PHARMA, INC.EVP, Chief Medical Officer Aug 7, 2018 to Jun 14, 2019⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

MetaVia Inc. MTVA20,568 shares⁵$28.2K at $1.37Jun 8, 2026
AGILE THERAPEUTICS INC2,066 shares⁶Jun 9, 2022
Endo International plc ENDP0 shares⁷Jul 15, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 8, 2026Granted 17,186 shares of MetaVia Inc.⁵
Jun 30, 2025Granted 28,147 shares of MetaVia Inc.⁸
Jun 7, 2024Granted 5,051 shares of MetaVia Inc.⁹
Dec 1, 2023Granted 7,157 shares of MetaVia Inc.¹⁰
Dec 1, 2023Granted 25,000 shares of MetaVia Inc.¹⁰
Jul 15, 2022Returned to company 280,373 shares of Endo International plc⁷
Jun 9, 2022Granted 670 shares of AGILE THERAPEUTICS INC⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARMetaVia Inc., Board member
2
SEC EDGAREndo International plc, Executive VP, Global R&D
3
SEC EDGARAGILE THERAPEUTICS INC, Board member
4
SEC EDGARANTARES PHARMA, INC., EVP, Chief Medical Officer
5
SEC EDGARMetaVia Inc. shares after the filing of Jun 8, 2026
6
SEC EDGARAGILE THERAPEUTICS INC shares after the filing of Jun 9, 2022
7
SEC EDGAREndo International plc shares after the filing of Jul 15, 2022
8
SEC EDGARForm 4 filed Jul 1, 2025
9
SEC EDGARForm 4 filed Jun 7, 2024
10
SEC EDGARForm 4 filed Dec 4, 2023